Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study | Psychological Medicine | Cambridge Core (original) (raw)

References

Bremmer, MA, Beekman, AT, Deeg, DJ, Penninx, BW, Dik, MG, Hack, CE, Hoogendijk, WJ (2008). Inflammatory markers in late-life depression: results from a population-based study. Journal of Affective Disorders 106, 249–255.CrossRefGoogle ScholarPubMed

Brunner, E, Davey Smith, G, Marmot, M, Canner, R, Beksinska, M, O'Brien, J (1996). Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 347, 1008–1013.CrossRefGoogle ScholarPubMed

Brunner, E, Shipley, MJ, Blane, D, Smith, GD, Marmot, MG (1999). When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. Journal of Epidemiology and Community Health 53, 757–764.CrossRefGoogle ScholarPubMed

Carney, RM, Freedland, KE, Miller, GE, Jaffe, AS (2002). Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. Journal of Psychosomatic Research 53, 897–902.CrossRefGoogle ScholarPubMed

Cyranowski, JM, Marsland, AL, Bromberger, JT, Whiteside, TL, Chang, Y, Matthews, KA (2007). Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain, Behavior, and Immunity 21, 229–237.CrossRefGoogle ScholarPubMed

Danese, A, Pariante, CA, Caspi, A, Taylor, A, Poulton, R (2007). Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences USA 104, 1319–1324.CrossRefGoogle Scholar

Danesh, J, Wheeler, JG, Hirschfield, GM, Eda, S, Eiriksdottir, G, Rumley, A, Lowe, GD, Pepys, MB, Gudnason, V (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 350, 1387–1397.CrossRefGoogle Scholar

Dantzer, R, Castanon, N, Lestage, J, Moreau, M, Capuron, L (2006). Inflammation, sickness behaviour and depression. In Depression and Physical Illness (ed. Steptoe, A.), pp. 265–279. Cambridge University Press: Cambridge.CrossRefGoogle Scholar

Dantzer, R, Kelley, KW (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity 21, 153–160.CrossRefGoogle ScholarPubMed

Dentino, AN, Pieper, CF, Rao, MK, Currie, MS, Harris, T, Blazer, DG, Cohen, HJ (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. Journal of the American Geriatrics Society 47, 6–11.CrossRefGoogle ScholarPubMed

Elovainio, M, Keltikangas-Jarvinen, L, Pulkki-Raback, L, Kivimaki, M, Puttonen, S, Viikari, L, Rasanen, L, Mansikkaniemi, K, Viikari, J, Raitakari, OT (2006). Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychological Medicine 36, 797–805.CrossRefGoogle ScholarPubMed

Fogel, J, Eaton, WW, Ford, DE (2006). Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up. Acta Psychiatrica Scandinavica 113, 36–43.CrossRefGoogle Scholar

Ford, DE, Erlinger, TP (2004). Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 164, 1010–1014.CrossRefGoogle ScholarPubMed

Frasure-Smith, N, Lesperance, F (2006). Recent evidence linking coronary heart disease and depression. Canadian Journal of Psychiatry 51, 730–737.CrossRefGoogle Scholar

Gabay, C, Kushner, I (1999). Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340, 448–454.CrossRefGoogle ScholarPubMed

Goldberg, D (1972). The Detection of Psychiatric Illness by Questionnaire. Maudsley Monograph no. 21. Oxford University Press: London.Google Scholar

Goldberg, DP, Hillier, VF (1979). A scaled version of the General Health Questionnaire. Psychological Medicine 9, 139–145.CrossRefGoogle ScholarPubMed

Kiecolt-Glaser, JK, McGuire, L, Robles, TF, Glaser, R (2002). Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 53, 83–107.CrossRefGoogle ScholarPubMed

Kingman, A, Zion, G (1994). Some power considerations when deciding to use transformations. Statistics in Medicine 13, 769–783.CrossRefGoogle ScholarPubMed

Kumari, M, Head, J, Marmot, M (2004). Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Archives of Internal Medicine 164, 1873–1880.CrossRefGoogle ScholarPubMed

Kuo, HK, Yen, CJ, Chang, CH, Kuo, CK, Chen, JH, Sorond, F (2005). Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurology 4, 371–380.CrossRefGoogle ScholarPubMed

Kuper, H, Marmot, M (2003). Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study. Journal of Epidemiology and Community Health 57, 147–153.CrossRefGoogle ScholarPubMed

Li, CY, Sung, FC (1999). A review of the healthy worker effect in occupational epidemiology. Occupational Medicine 49, 225–229.CrossRefGoogle ScholarPubMed

Liukkonen, T, Silvennoinen-Kassinen, S, Jokelainen, J, Rasanen, P, Leinonen, M, Meyer-Rochow, VB, Timonen, M (2006). The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825–830.CrossRefGoogle ScholarPubMed

Maes, M, Meltzer, HY, Bosmans, E, Bergmans, R, Vandoolaeghe, E, Ranjan, R, Desnyder, R (1995 a). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders 34, 301–309.CrossRefGoogle ScholarPubMed

Maes, M, Vandoolaeghe, E, Ranjan, R, Bosmans, E, Bergmans, R, Desnyder, R (1995 b). Increased serum interleukin-1-receptor-antagonist concentrations in major depression. Journal of Affective Disorders 36, 29–36.CrossRefGoogle ScholarPubMed

Mancini, GB, Dahlof, B, Diez, J (2004). Surrogate markers for cardiovascular disease: structural markers. Circulation 109 (Suppl. 1), IV22–IV30.CrossRefGoogle ScholarPubMed

Marmot, M, Brunner, E (2005). Cohort profile: the Whitehall II study. International Journal of Epidemiology 34, 251–256.CrossRefGoogle ScholarPubMed

Marmot, MG, Smith, GD, Stansfeld, S, Patel, C, North, F, Head, J, White, I, Brunner, E, Feeney, A (1991). Health inequalities among British civil servants: the Whitehall II study. Lancet 337, 1387–1393.CrossRefGoogle ScholarPubMed

Myers, GL, Rifai, N, Tracy, RP, Roberts, WL, Alexander, RW, Biasucci, LM, Catravas, JD, Cole, TG, Cooper, GR, Khan, BV, Kimberly, MM, Stein, EA, Taubert, KA, Warnick, GR, Waymack, PP (2004). CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 110, e545–e549.CrossRefGoogle Scholar

Nicholson, A, Fuhrer, R, Marmot, M (2005). Psychological distress as a predictor of CHD events in men: the effect of persistence and components of risk. Psychosomatic Medicine 67, 522–530.CrossRefGoogle ScholarPubMed

Pace, TW, Mletzko, TC, Alagbe, O, Musselman, DL, Nemeroff, CB, Miller, AH, Heim, CM (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. American Journal of Psychiatry 163, 1630–1633.CrossRefGoogle ScholarPubMed

Patel, V, Araya, R, Chowdhary, N, King, M, Kirkwood, B, Nayak, S, Simon, G, Weiss, HA (2008). Detecting common mental disorders in primary care in India: a comparison of five screening questionnaires. Psychological Medicine 38, 221–228.CrossRefGoogle ScholarPubMed

Penninx, BW, Kritchevsky, SB, Yaffe, K, Newman, AB, Simonsick, EM, Rubin, S, Ferrucci, L, Harris, T, Pahor, M (2003). Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biological Psychiatry 54, 566–572.CrossRefGoogle ScholarPubMed

Pradhan, AD, Manson, JE, Rifai, N, Buring, JE, Ridker, PM (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 286, 327–334.CrossRefGoogle ScholarPubMed

Raison, CL, Capuron, L, Miller, AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24–31.CrossRefGoogle ScholarPubMed

Ranjit, N, Diez-Roux, AV, Shea, S, Cushman, M, Seeman, T, Jackson, SA, Ni, H (2007). Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Archives of Internal Medicine 167, 174–181.CrossRefGoogle ScholarPubMed

Rasul, F, Stansfeld, SA, Smith, GD, Shlomo, YB, Gallacher, J (2007). Psychological distress, physical illness and risk of myocardial infarction in the Caerphilly study. Psychological Medicine 37, 1305–1313.CrossRefGoogle ScholarPubMed

Royal College of Physicians, Royal College of Psychiatrists, Royal College of General Practitioners (1995). Alcohol and the Heart in Perspective: Sensible Limits Reaffirmed. Royal College of Physicians, Royal College of Psychiatrists, Royal College of General Practitioners: London.Google Scholar

Sothern, RB, Roitman-Johnson, B, Kanabrocki, EL, Yager, JG, Roodell, MM, Weatherbee, JA, Young, MR, Nenchausky, BM, Scheving, LE (1995). Circadian characteristics of circulating interleukin-6 in men. Journal of Allergy and Clinical Immunology 95, 1029–1035.CrossRefGoogle ScholarPubMed

Stansfeld, SA, Head, J, Fuhrer, R, Wardle, J, Cattell, V (2003). Social inequalities in depressive symptoms and physical functioning in the Whitehall II study: exploring a common cause explanation. Journal of Epidemiology and Community Health 57, 361–367.CrossRefGoogle ScholarPubMed

Stansfeld, SA, Marmot, MG (1992). Social class and minor psychiatric disorder in British civil servants: a validated screening survey using the General Health Questionnaire. Psychological Medicine 22, 739–749.CrossRefGoogle ScholarPubMed

Stewart, JC, Janicki, DL, Muldoon, MF, Sutton-Tyrrell, K, Kamarck, TW (2007). Negative emotions and 3-year progression of subclinical atherosclerosis. Archives of General Psychiatry 64, 225–233.CrossRefGoogle ScholarPubMed

Tiemeier, H, Hofman, A, van Tuijl, HR, Kiliaan, AJ, Meijer, J, Breteler, MM (2003). Inflammatory proteins and depression in the elderly. Epidemiology 14, 103–107.CrossRefGoogle ScholarPubMed

Watson, R, Deary, IJ, Shipley, B (2008). A hierarchy of distress: Mokken scaling of the GHQ-30. Psychological Medicine 38, 575–579.CrossRefGoogle ScholarPubMed

Wener, MH, Daum, PR, McQuillan, GM (2000). The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. Journal of Rheumatology 27, 2351–2359.Google ScholarPubMed

Wichers, M, Maes, M (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 5, 375–388.CrossRefGoogle ScholarPubMed

Woodward, M, Rumley, A, Lowe, GD, Tunstall-Pedoe, H (2003). C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 122, 135–141.CrossRefGoogle ScholarPubMed

Woodward, M, Rumley, A, Tunstall-Pedoe, H, Lowe, GD (1999). Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 104, 246–257.CrossRefGoogle ScholarPubMed

Yaffe, K, Kanaya, A, Lindquist, K, Simonsick, EM, Harris, T, Shorr, RI, Tylavsky, FA, Newman, AB (2004). The metabolic syndrome, inflammation, and risk of cognitive decline. Journal of the American Medical Association 292, 2237–2242.CrossRefGoogle ScholarPubMed